UK markets closed

Teladoc Health, Inc. (4LL.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.90-0.09 (-0.93%)
At close: 09:20PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.66B
Enterprise value 2.11B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.68
Price/book (mrq)0.80
Enterprise value/revenue 0.88
Enterprise value/EBITDA 13.40

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-55.76%
S&P500 52-week change 323.23%
52-week high 327.42
52-week low 39.90
50-day moving average 312.02
200-day moving average 316.11

Share statistics

Avg vol (3-month) 3614
Avg vol (10-day) 3825
Shares outstanding 5169.59M
Implied shares outstanding 6172.14M
Float 8167.97M
% held by insiders 10.81%
% held by institutions 176.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -8.90%
Operating margin (ttm)-11.93%

Management effectiveness

Return on assets (ttm)-3.25%
Return on equity (ttm)-10.18%

Income statement

Revenue (ttm)2.62B
Revenue per share (ttm)15.80
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)N/A
EBITDA 46.03M
Net income avi to common (ttm)-233.03M
Diluted EPS (ttm)-1.29
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.1B
Total cash per share (mrq)6.47
Total debt (mrq)1.59B
Total debt/equity (mrq)69.48%
Current ratio (mrq)3.82
Book value per share (mrq)13.52

Cash flow statement

Operating cash flow (ttm)345.78M
Levered free cash flow (ttm)306.86M